Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1997-3-11
pubmed:abstractText
The B7 family of costimulatory molecules provides the second signal necessary for activation of T cells. In the absence of the second signal, responding T cells become anergic. Although predominantly expressed on professional APCs, recent evidence shows that the B7 molecules are also expressed on T cells. To study the functions of B7 molecules on T cells, we transfected murine B7.1 (CD80) and B7.2 (CD86) cDNAs into the EL4 T cell thymoma cell line and examined the transfectants for their ability to costimulate T cell proliferation in vitro and to induce antitumor immunity in vivo. Here we show that although EL4-B7.1 cells costimulate T cells and induce tumor regression, EL4-B7.2 transfectants failed to costimulate T cell proliferation or induce tumor regression. To understand the cellular basis for this difference, we examined the binding of EL4-B7.1 and EL4-B7.2 to CTLA4 and CD28. Whereas EL4-B7.1 cells bound both CTLA4-Ig and CD28-Ig, EL4-B7.2 transfectants preferentially bound CTLA4-Ig, but not CD28-Ig. Similar binding data were obtained with freshly isolated murine T cells, which have been shown to constitutively express B7.2. Our data suggest, therefore, that B7.2 expressed on T cells may not costimulate but instead inhibit the T cell response by preferential binding to CTLA4.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0022-1767
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
158
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2025-34
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:9036945-Animals, pubmed-meshheading:9036945-Antigens, CD, pubmed-meshheading:9036945-Antigens, CD28, pubmed-meshheading:9036945-Antigens, CD86, pubmed-meshheading:9036945-Antigens, Differentiation, pubmed-meshheading:9036945-CTLA-4 Antigen, pubmed-meshheading:9036945-Cell Division, pubmed-meshheading:9036945-Female, pubmed-meshheading:9036945-Immunoconjugates, pubmed-meshheading:9036945-Lymphocyte Activation, pubmed-meshheading:9036945-Membrane Glycoproteins, pubmed-meshheading:9036945-Mice, pubmed-meshheading:9036945-Mice, Inbred BALB C, pubmed-meshheading:9036945-Mice, Inbred C57BL, pubmed-meshheading:9036945-Protein Binding, pubmed-meshheading:9036945-T-Lymphocytes, pubmed-meshheading:9036945-Thymoma, pubmed-meshheading:9036945-Thymus Neoplasms, pubmed-meshheading:9036945-Transfection, pubmed-meshheading:9036945-Tumor Cells, Cultured
pubmed:year
1997
pubmed:articleTitle
B7.2 expressed by T cells does not induce CD28-mediated costimulatory activity but retains CTLA4 binding: implications for induction of antitumor immunity to T cell tumors.
pubmed:affiliation
Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't